Single-cell sequencing comparing CCR5+ vs. CCR5− breast cancer cells from within a heterogeneous population of breast cancer patients revealed dramatic enrichment of pathways governing ribosomal biogenesis [11]. This evidence concerns the gene CCR5 and breast cancer.